LIBRAINFU

Libra Infusions Limited · Pharmaceuticals and Chemicals · Cat Z

4/100

High risk

৳638.1

Score breakdown

Technical read

RSI (14)49.1

MACDbearish

Bollingerinside bands (-0.8σ)

Price cycle (Wyckoff)MARKUP

Health trenddeteriorating

Flow pressureneutral

Valuation

Fair value ()

Upside—

Dividend yield+0.50%

Fundamental verdictAT-RISK

Confidence—

Levels

Resistance

৳640

৳663.3

৳685

৳705.8

Support

৳633.4

৳613.4

৳595

৳575.1

Historical bounce zones

Oct 15, 2024: ৳790→৳932 +18%

Oct 28, 2024: ৳760.4→৳927 +22%

Nov 11, 2024: ৳810→৳948.1 +17%

Jan 2, 2025: ৳761.2→৳928.9 +22%

May 7, 2025: ৳720→৳842 +17%

Nov 13, 2025: ৳595→৳719 +21%

Jan 25, 2026: ৳610→৳739 +21%

May 20, 2026: ৳547.1→৳685 +25%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -5% / -1% / 3.8%

30-day 41% vs 42% market avg Typical move: -8.9% / -1.8% / 6.6%

Signals: Three Outside Down

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readAVOID (dormant/dirty)

Reference stopn/a

Reference target—

Timing notestay out

Elevated (score 197) — acceptable only with real earnings and sponsor backing; artificial-activity lens applies. Phase: DORMANT (-4% >200-MA, flow neut). Z-cat. SLOW-BURN evasion: +119% stretch / 153% run on only 0 circuits — score UNDER-rates it; consistent with concentrated-operator-style behaviour. Solvency GREY zone (Altman Z 2.02, RECOVERING) — watch balance sheet. [fundamentals AT-RISK (dividend cut risk), payout 2000.0%, yield 0.5%]